ESLAW short interest
Estrella Immunopharma Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 27,511 |
|---|---|
| Change vs prior report | -2,046 (-6.9%) |
| Change over six months | +11.5% |
| Days to cover | 58.91 (sector: 3.78) |
| Average daily volume | 467 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
ESLAW short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 27,511 | -6.9% | 58.91 | 467 |
| 2026-09-15 | 29,557 | -0.7% | 869.32 | 34 |
| 2026-08-31 | 29,765 | -1.2% | 118.59 | 251 |
| 2026-08-14 | 30,142 | -8.0% | 45.95 | 656 |
| 2026-07-31 | 32,761 | +11.0% | 29.30 | 1,118 |
| 2026-07-15 | 29,509 | +6.0% | 18.44 | 1,600 |
| 2026-06-30 | 27,836 | +1.5% | 44.18 | 630 |
| 2026-06-15 | 27,436 | +4.3% | 9.45 | 2,902 |
| 2026-05-29 | 26,312 | -6.5% | 6.48 | 4,059 |
| 2026-05-15 | 28,139 | +16.1% | 12.62 | 2,230 |
| 2026-04-30 | 24,235 | +2.0% | 113.25 | 214 |
| 2026-04-15 | 23,765 | -3.6% | 15.73 | 1,511 |
| 2026-03-31 | 24,665 | +0.2% | 70.07 | 352 |
| 2026-03-13 | 24,615 | -5.2% | 175.82 | 140 |
| 2026-02-27 | 25,953 | -1.4% | 15.48 | 1,677 |
| 2026-02-13 | 26,312 | +54.2% | 4.75 | 5,539 |
| 2026-01-30 | 17,060 | +0.0% | 7.77 | 2,196 |
| 2026-01-15 | 17,060 | +189.0% | 5.28 | 3,229 |
| 2025-12-31 | 5,904 | +0.0% | 1.67 | 3,525 |
| 2025-12-15 | 5,904 | +66.7% | 1.00 | 19,899 |
| 2025-11-28 | 3,541 | -24.8% | 2.77 | 1,277 |
| 2025-11-14 | 4,708 | +6.8% | 1.00 | 6,345 |
| 2025-10-31 | 4,408 | -24.4% | 1.00 | 4,872 |
| 2025-10-15 | 5,830 | +35.3% | 1.00 | 8,578 |
| 2025-09-30 | 4,308 | -16.5% | 1.00 | 5,127 |
import finzdata as yf
yf.Ticker("ESLAW").short_interest # every report since 2017
yf.Client().short_interest(["ESLAW"], start="2018-01-01")Healthcare short interest · ESLAW price history · Who owns ESLAW · All short interest